This week's RVI meeting (Wednesday 1/17, 8:00am, offices of TechSpring) included two presentations to see if we are interested in starting due diligence:
- Kalion - Brings cleaner, greener, cheaper molecules to market. Specifically, Kalion has found a way to produce two platform chemicals, glucaric acid and 3-HBL, using synthetic biology. Kalion is an RVI portfolio company based in Milton, MA.
- Cambridge Blockchain - Puts control of personal identity data back in the hands of the end user. Cambridge Blockchain is an RVI portfolio company, and is raising Series A funding.